United States · Funded startup

Who invested in Novalar Pharmaceuticals

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 1 Nov 2026

$31Mraised across 2 rounds since 2007, from 2 sources

$30MSeries D$1.0MDebt
Latest round
Debt, $1.0MJul 2010
Biggest round
$30MSeries D · Nov 2007
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

200820092010
$30MSeries D$1.0MDebt
First round
Series D, $30M
Nov 2007
Biggest round
$30M
Series D · Nov 2007
Between rounds
2.7 years
from the last two

The rounds

  1. Jul 2010
    Debt$1.0M

    No investor was named in the report.

    From a historical funding recordSEC filing: $1.0M sold, first sale Jul 2010

  2. Nov 2007
    Series D$30M3 new

    From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Domain AssociatesVC firm1round
SR OneCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Novalar Pharmaceuticals

Who invested in Novalar Pharmaceuticals?

Novalar Pharmaceuticals's investors include Domain Associates, SR One and Montreux Growth Partners.

How much has Novalar Pharmaceuticals raised?

Novalar Pharmaceuticals has raised $31M across 2 rounds since 2007.

When did Novalar Pharmaceuticals last raise?

Novalar Pharmaceuticals's most recent round was a Debt of $1.0M in Jul 2010.

What was Novalar Pharmaceuticals's biggest round?

Novalar Pharmaceuticals's largest round on record is $30M (Series D), in Nov 2007.

Who backed Novalar Pharmaceuticals first?

Novalar Pharmaceuticals's first round on record, in Nov 2007, was backed by Domain Associates, SR One and Montreux Growth Partners.

What stage is Novalar Pharmaceuticals at?

Novalar Pharmaceuticals's latest named round is a Debt, in Jul 2010.

Where is Novalar Pharmaceuticals based?

Novalar Pharmaceuticals is based in the United States.

Companies like Novalar Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.